The product does not meet quality requirements due to an out-of-specification result for friability of uncoated tablets; the sample contained crushed, cracked or broken tablets. Potential effects: possible uneven dosing of the drug and reduced therapeutic efficacy.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Viglita (Vildagliptin) 50 mg due to suspension of all batches; patients should contact their doctor or pharmacist to determine further treatment and a possible change of medication.
The Chief Pharmaceutical Inspector suspended the marketing of Viglita (Vildagliptin) 50 mg tablets throughout the country for all batches and granted the decision immediate enforceability; previously,...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related